FDA Approves IsoPSA as an Adjunct Test for Prostate Cancer Diagnosis, Potentially Reducing the Need for Biopsy

2025.12.15

Rare Disease Diagnosis Shifts from Single-Gene Testing to the NGS Era

2025.12.09

Automated Mass Spectrometry System Receives FDA 510(k) Clearance, with Plans for Introduction in Korea

2025.11.17

Dow Biomedica and 10x Genomics Spotlight the Future of Precision Cell Therapy at KSGCT 2025

2025.11.10